Off-label applications for SSRIs
- PMID: 12924832
Off-label applications for SSRIs
Abstract
Selective serotonin reuptake inhibitors (SSRIs) are widely used because of their safety, tolerability, and demonstrated efficacy across a broad range of clinical conditions. Medical literature supports the use of SSRIs for the treatment of many conditions outside of the indications approved by the U.S. Food and Drug Administration. SSRIs offer a reasonable alternative to traditional therapy for generalized anxiety disorder. A side effect of SSRIs coincidentally provides therapy for premature ejaculation. SSRIs may reduce the frequency and severity of migraine headaches and are possibly effective in reducing the pain of diabetic neuropathy. When taken in combination with tricyclic antidepressants, SSRis offer more potent therapy for fibromyalgia than either agent alone. SSRIs appear to be effective in some patients with neurocardiogenic syncope that is refractory to standard therapies. Clinical experience supported by ongoing research continues to expand on the broad array of therapeutic applications for this class of medication.
Comment in
-
Off-label use of prescription drugs.Am Fam Physician. 2003 Aug 1;68(3):425-7. Am Fam Physician. 2003. PMID: 12924828 No abstract available.
-
Off-label uses for selective serotonin reuptake inhibitors.Am Fam Physician. 2005 Jan 1;71(1):43; author reply 43, 46. Am Fam Physician. 2005. PMID: 15663023 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
